When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With ATRS Stock Today?
Antares Pharma Inc (ATRS) stock is unmoved -0.08% while the S&P 500 is higher by 0.27% as of 10:31 AM on Tuesday, Nov 2. ATRS is unmoved $0.00 from the previous closing price of $3.79 on volume of 93,718 shares. Over the past year the S&P 500 is higher by 39.75% while ATRS is higher by 35.36%. ATRS earned $0.38 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 10.06.
More About Antares Pharma Inc
Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's products include OTREXUP, Elestrin, Gelnique, Makena, and others.
Click Here to get the full Stock Report for Antares Pharma Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter